Luciana Viana

Dr. Luciana Viana


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 November 2014 in Diabetes Care
Verified
Journal Article
Closed access
LVLuciana Viana
Luciana Viana
JGJorge Luiz Gross
Jorge Luiz Gross
MAMirela Jobim Azevedo
Mirela Jobim Azevedo
OBJECTIVE: Diet is the cornerstone treatment of patients with gestational diabetes mellitus (GDM), but its role in maternal and newborn outcomes has been scarcely studied. The purpose of this study was to analyze the efficacy of dietary interventions on maternal or newborn outcomes in patients with GDM. RESEARCH DESIGN AND METHODS: A systematic review and meta-analysis of randomized clinical trials (RCTs) of dietary intervention in GDM or pregnancy with hyperglycemia was performed. MEDLINE, Embase, ClinicalTrials.gov, Cochrane, and Scopus were searched through to March 2014. The main evaluated maternal outcomes were proportion of patients using insulin and proportion of cesarean delivery; the newborn outcomes were proportion of macrosomia and hypoglycemia and newborn weight. RESULTS: From 1,170 studies, nine RCTs, including 884 women aged 31.5 years (28.7–33.2) with 27.4 weeks (24.1–30.3) of gestation, were eligible. We divided the RCTs according to the type of dietary intervention: low glycemic index (GI) (n = 4; 257 patients), total energy restriction (n = 2; 425 patients), low carbohydrates (n = 2; 182 patients), and others (n = 1; 20 patients). Diet with low GI reduced the proportion of patients who used insulin (relative risk 0.767 [95% CI 0.597, 0.986]; P = 0.039) and the newborn birth weight (weight mean differences −161.9 g [95% CI −246.4, −77.4]; P = 0.000) as compared with control diet. Total restriction and low carbohydrate diets did not change either maternal or newborn outcomes. CONCLUSIONS: A low GI diet was associated with less frequent insulin use and lower birth weight than control diets, suggesting that it is the most appropriate dietary intervention to be prescribed to patients with GDM.

17 February 2016 in Trials
Verified
Journal Article
Open access
PDF file
LVLuciana Viana
Luciana Viana
MGMARILIA GOMES
MARILIA GOMES
LZLenita Zajdenverg
Lenita Zajdenverg
EPElizabeth Joao Pavin
Elizabeth Joao Pavin
MAMirela Jobim Azevedo
Mirela Jobim Azevedo
Brazilian records on glycemic control in patients with type 1 diabetes show treatment efficacy. Poor patient adherence to therapeutic proposals influences these results and can be associated with social, psychological, and economic aspects, besides others factors. The aim of this study was to evaluate the efficacy of psychological, telecare, and educational interventions to improve treatment compliance among patients with type 1 diabetes. Compliance was assessed indirectly using reduction of glycated hemoglobin (HbA1c) as the principal outcome measure. Systematic review and meta-analyses of randomized controlled clinical trials (RCTs) were performed using Medline, Embase, Cochrane and Scopus databases up to April 2015. The following medical subject headings were used: Diabetes Mellitus, Type 1, Patient Compliance or Adherence, Hemoglobin A, glycated, and Randomized Controlled Trial. The principal outcome was change in HbA1c between baseline and follow-up. Where appropriate, trials were combined in meta-analysis using fixed effects models. From 191 articles initially identified, 57 were full text reviewed, and 19 articles met the inclusion criteria providing data from 1782 patients (49.4 % males, age 18 years). The RCTs (2 to 24 months in duration) were divided into four groups according to type of intervention: psychology (seven studies; 818 patients), telecare (six studies; 494 patients); education (five studies; 349 patients), and psychoeducation (one study; 153 patients). All studies reported some type of adherence measurement of the interventions. Decrease in HbA1c was observed after psychology (MD −0.310; 95 % CI, −0.599 to −0.0210, P = 0.035) but not after telecare (MD −0.124 %; 95 % CI, −0.268, 0.020; P = 0.090) or educational (MD −0.001; 95 % CI, −0.202, 0.200; P = 0.990) interventions. Psychological approaches to improve adherence to diabetes care treatment modestly reduced HbA1c in patients with type 1 diabetes; telecare and education interventions did not change glycemic control. However, the limited number of studies included as well as their methodological quality should be taken into account.

18 September 2013 in BMJ Open
Verified
Journal Article
Open access
PDF file
LVLuciana Viana
Luciana Viana
CLCristiane B Leitão
Cristiane B Leitão
CKCaroline K Kramer
Caroline K Kramer
AZAlessandra T N Zucatti
Alessandra T N Zucatti
DJDeborah L Jezini
Deborah L Jezini
JGJorge L Gross
Jorge L Gross
Objectives: To describe the clinical profile of Brazilian patients with type 2 diabetes attending the public healthcare system and identify factors associated with poor glycaemic control.Design: Cross-sectional study.Setting: 14 centres in five regions of Brazil, including primary care units and outpatient clinics of University Hospitals.Participants: Patients with type 2 diabetes attending outpatient clinics of public healthcare system.Main outcome measured: Glycated haemoglobin (HbA1c), centrally measured by high-performance liquid chromatography (National Glycohemoglobin Standardization Program certified).Results: A total of 5750 patients aged 61±10 years, with 11±8 years of diabetes duration (66% women, 56% non-white, body mass index: 28.0±5.3 kg/m2) were analysed. Mean HbA1c was 8.6±2.2%, and median HbA1c was 8.1% (6.9% to 9.9%). HbA1c <7% was observed in only 26% of patients. Mean HbA1c was higher (p < 0.01) in the North (9.0±2.6%) and Northeast (8.9±2.4%) than in the Midwest (8.1±2%), Southeast (8.4±2.1%) and South regions (8.3±1.9%). Using the cut-off value of HbA1c above the median, age (0.986 (0.983 to 0.989)), white ethnicity (0.931 (0.883 to 0.981)) and being from Midwest region (0.858 (0.745 to 0.989)) were protective factors, while diabetes duration (1.015 (1.012 to 1.018)), use of insulin (1.710 (1.624 to 1.802)) and living in the Northeast region (1.197 (1.085 to 1.321)) were associated with HbA1c >8%.Conclusions: The majority of Brazilian patients with type 2 diabetes attending the public healthcare system had HbA1c levels above recommended targets. The recognition of Northeast residents and non-white patients as vulnerable populations should guide future policies and actions to prevent and control diabetes.

6 February 2019 in Nutrients
Verified
Journal Article
Open access
PDF file
CCCláudia M Carvalho
Cláudia M Carvalho
LGLuiza Azevedo Gross
Luiza Azevedo Gross
MAMirela Jobim de Azevedo
Mirela Jobim de Azevedo
LVLuciana Viana
Luciana Viana
Fiber intake is associated with better glycemic control being an important non-pharmacological treatment for diabetes (DM). We hypothesize that a dietary fiber intake can bring benefits to diabetic kidney disease (DKD), improving renal outcomes. This systematic review aimed to evaluate the effect of dietary fiber (supplemental or dietary pattern rich in fiber) on DKD. We searched six databases to identify clinical trials that reported fiber intake and renal outcomes (albuminuria, proteinuria, estimated glomerular filtration rate (eGFR) dialysis) in patients with DM. From 1814 studies, 48 papers were fully evaluated. In the end, seven trials (161 patients, aged 58.3 years, 49% females) were included. The studies were organized into three categories (vegetarian, Dietary Approaches to Stop Hypertension (DASH) diet, and fiber supplement), two evaluated supplements and five dietary patterns. Vegetarian diet reduced albuminuria in three trials, two in patients with type 1 DM and one in patients with type 2 DM; and one study demonstrated a change in the eGFR in type 1 DM. The individual quality of the studies was low/uncertain. A vegetarian dietary pattern may have a beneficial effect on these renal outcomes. However, the individual effect of the intake of fiber on DKD not was possible to be evaluated.

21 November 2012 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
LVLuciana Viana
Luciana Viana
CLCristiane B Leitão
Cristiane B Leitão
MGMaria de Fátima Grillo
Maria de Fátima Grillo
EREnnio P C C Rocha
Ennio P C C Rocha
JBJuliana K Brenner
Juliana K Brenner
JGJorge L Gross
Jorge L Gross
Background: The American Diabetes Association (ADA) has published several diabetes treatment algorithms, but none have been tested in real-life settings. The aim of this study is to analyze the feasibility of achieving and/or maintaining HbA1c levels <7.0% using current diabetes treatment guidelines and the resources available in the public health care system of Brazil. Methods: A one-year, single-arm interventional study was conducted with type 2 diabetes patients in a primary care unit. Intervention consisted of intensification of lifestyle changes and sequential prescription of drugs based on ADA guidelines using the medications available through the publicly funded Unified Health System (Sistema Único de Saúde, SUS). Results: Ninety patients (age: 62.7±10.4 years; diabetes duration: 8.2±9.1 years) completed the trial. During the intervention period, increases were observed in number of oral antidiabetic agent (OAD) classes per patient (1.50±0.74 vs. 1.67±0.7; p=0.015), OAD pills per patient (2.64±1.89 vs. 3.33±2.23 pills/patient; p <0.001), insulin dosage (0.20±0.29 vs.0.50±0.36 UI/kg/day; p=0.008) and number of patients on insulin (19 [21%] vs. 31 [34%]; p<0.01), but no improvement in HbA1c (7.2±1.6% vs. 7.3±1.5%; p=0.453) or frequency of patients on target, defined as HbA1c <7% (53.3% vs. 48.9%; p=0.655). Patients with baseline HbA1c <7% had a small increase in HbA1c during the trial (6.3±0.4 vs. 6.7±0.9%; p=0.002). No such change was observed in those with baseline HbA1c ≥7%. Conclusions: In this group of patients with a mean baseline HbA1c of 7.2%, implementation of 2006/2009 ADA/EASD guidelines led to achievement of the therapeutic goal of HbA1c <7% in a small proportion of patients.

12 September 2013 in Diabetology & Metabolic Syndrome
Verified
Journal Article
Open access
PDF file
LVLuciana Viana
Luciana Viana
CLCristiane B Leitão
Cristiane B Leitão
MGMaria F Grillo
Maria F Grillo
EREnnio P C C Rocha
Ennio P C C Rocha
JBJuliana K Brenner
Juliana K Brenner
JGJorge L Gross
Jorge L Gross
Hypertension frequently coexists with type 2 diabetes (DM), and increases the risk of cardiovascular outcomes. The aim of the study was to obtain/maintain blood pressure (BP) goals (ADA/JNC 7) according to a stepwise algorithm using the medication supplied by the Brazilian government.